Imagenetix, Inc. to Present at the 2009 RedChip New York Equities ... ( SAN DIEGO Sept. 24 ...)

Imagenetix, Inc. to Present at the 2009 RedChip New York Equities Conference

Date:9/24/2009

SAN DIEGO, Sept. 24 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced today that their Chief Executive Officer, William P. Spencer and Chief Financial Officer, Lowell W. Giffhorn, are scheduled to present at the 2009 RedChip New York Equities Conference being held in New York City on September 30th and October 1st, 2009. The Company's presentation is scheduled for 2:05 p.m. Eastern time on Wednesday, September 30, 2009 at the NASDAQ MarketSite (4 Times Square, at 43rd and Broadway).

Mr. Giffhorn will provide an overview on Imagenetix, Inc. which will also highlight it's flagship product InflameAway Celadrin(R), the introduction of BioGuard(TM) and the status of it's periodontal drug candidate, 1TDC.

Company presentations will be webcast live and archived for 90 days at http://www.RedChip.com.

For additional information or to schedule a one-on-one meeting with Imagenetix, Inc. at this event, please contact Jon Cunningham at 407-644-4256, Ext. 107, or email conference@redchip.com.

About Imagenetix

Imagenetix, based in San Diego, California, is an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health on a global basis. Imagenetix develops and formulates propriety over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners. Imagenetix is the creator of InflameAway Celadrin(R). Please visit, www.celadrin.c
'/>"/>

SOURCE Imagenetix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Imagenetix, Inc. Announces Interview With Bloomberg Radio
2. Imagenetix, Inc. Reports First Quarter 2010 Results
3. Imagenetix, Inc. Reports Second Quarter and Six Month Results
4. Fortebio, Inc. to Present at UBS Global Life Sciences Conference
5. Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
6. Covance to Present at UBS Global Life Sciences Conference
7. NeurogesX to Present at UBS Global Life Sciences Conference
8. Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO/ESMO on September 22, 2009
9. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
10. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
11. Viral Genetics Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference

Post Your Comments:

(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...

(Date:12/15/2009)... Minn., Dec. 15 The Mosaic Company (NYSE: ... fiscal year 2010 earnings results and financial tables on ... on the New York Stock Exchange. Results will ... ,, The Company will host a conference call with ... the results. The call will begin at 11:00 ...

(Date:12/15/2009)... PHILADELPHIA and LONDON, Dec. 15 ... Thomson Pharma ® has become the first ... trial protocol and outcome information. This highly anticipated ... Pharma customers this month. ,, ... trial intelligence from registries, publications, press releases, conferences, ...

(Date:12/14/2009)... -- Vermillion, Inc. (Pink Sheets: VRML), a ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice ... will be joining its board of directors ... ,, "Bill brings more than 20 years ... biotechnology," said Gail Page, Vermillion Executive Chairperson. ...

[0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials [0] Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors

... BEDMINSTER, N.J., Feb. 29 NPS,Pharmaceuticals, Inc. (Nasdaq: ... executive vice president, chief operating officer, and chief,executive ... Brothers,Eleventh Annual Global Healthcare Conference in Miami on ... presentation will be available as a live,webcast with ...

... Kendle (Nasdaq: KNDL ), a,leading, ... Vice President and Chief Marketing Officer Simon,Higginbotham ... James,Institutional Investors Conference. The conference will be ... Orlando, March 2-5, 2008. Kendle,s,presentation is scheduled ...

... Tests Based on Company,s microRNA ... Technology on Schedule for 2008, REHOVOT, Israel and ... ROSG ), a leading,molecular diagnostics company, today reported a narrower operating ... corresponding,period of 2006, and said it remains solidly on target for ...

NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results

(Date:12/16/2009)... Tom Bowman, an expert in communicating scientific issues ... has developed a series of graphics that translate key ... (IPCC) report for public audiences. These new graphics provide ... to make informed decisions about climate change risks and ... means to clearly and accurately communicate findings in the ...

(Date:12/16/2009)... Dec. 2 DigitalPersona, Inc., a ... today announced an agreement with IBM to ... biometric fingerprint technology on IBM SurePOS 500 ... allows point-of-sale applications to more easily and ... can be linked to the individuals who ...

(Date:12/16/2009)... 2009 National Instruments (Nasdaq: ... and control, and DENSO Robotics, a leader ... technology, today announced their collaboration to integrate ... robotic arms. The collaboration increases productivity and ... manufacturing applications. In today,s trend toward high-mix, ...

Breaking Biology News(10 mins):Bowman creates graphic translation of climate change data 2 DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2 National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2 National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3 National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4 National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5 Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 1 Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 2 Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 3 Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 1 Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 2 Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 1 Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 2 Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 3

[0] Bowman creates graphic translation of climate change data [0] DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems [0] National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics

... cancer survivors might one day avoid the prospect of ... that would involve using stem cells derived from their ... studying the potential these cells may have for regenerating ... researchers hope to prove that an injection of fat-derived ...

... response to higher global temperatures may be somewhat overstated ... to adjust to changing conditions, according to researchers from ... published April 28 by Science, a team led by ... percent more carbon will be stored in plants and ...

... A jumping gene first identified in a cabbage-eating moth may ... gene therapy, researchers say. , , They compared the ... insert themselves into a cell's DNA and produce a desired ... radiation therapy. , They found the piggyBac transposon was five ...

Other Biology News:Fat stem cells being studied as option for breast reconstruction 2 Plants' role in global warming re-examined 2 Jumping gene could provide non-viral alternative for gene therapy 2 Jumping gene could provide non-viral alternative for gene therapy 3

Fat stem cells being studied as option for breast reconstruction Plants' role in global warming re-examined Jumping gene could provide non-viral alternative for gene therapy

One-step, microplate or cuvet, colorimetric, detection range 0.01 g/dL to 5 g/dL. Procedure: 5 min....

MOUSE ANTI PROTEIN KINASE C BETA 2 Immunogen: Protein kinase C beta 2...

SHEEP ANTI DEHYDROEPIANDROSTERONE...

This issue concentrated on the purification of proteins for specific purposes (i.e. large-scale purification, purification for therapeutic use, etc.)...

Biology Products:

Albumin Colorimetric Assay Kit, QuantiChrom from BioAssay Systems Mouse Anti-Protein Kinase C Beta 2 Monoclonal Antibody, Unconjugated from AbD Serotec Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec Protein Purification Applications from Promega

Imagenetix, Inc. to Present at the 2009 RedChip New York Equities ...( SAN DIEGO Sept. 24 ...)